EP2411031A4 - Méthodes et compositions pour le traitement du cancer - Google Patents

Méthodes et compositions pour le traitement du cancer

Info

Publication number
EP2411031A4
EP2411031A4 EP10756546A EP10756546A EP2411031A4 EP 2411031 A4 EP2411031 A4 EP 2411031A4 EP 10756546 A EP10756546 A EP 10756546A EP 10756546 A EP10756546 A EP 10756546A EP 2411031 A4 EP2411031 A4 EP 2411031A4
Authority
EP
European Patent Office
Prior art keywords
cancer
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10756546A
Other languages
German (de)
English (en)
Other versions
EP2411031A2 (fr
Inventor
Isaac Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionovo Inc
Original Assignee
Bionovo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/553,878 external-priority patent/US20100069480A1/en
Application filed by Bionovo Inc filed Critical Bionovo Inc
Publication of EP2411031A2 publication Critical patent/EP2411031A2/fr
Publication of EP2411031A4 publication Critical patent/EP2411031A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
EP10756546A 2009-03-24 2010-03-01 Méthodes et compositions pour le traitement du cancer Withdrawn EP2411031A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16298809P 2009-03-24 2009-03-24
US17263909P 2009-04-24 2009-04-24
US12/553,878 US20100069480A1 (en) 2008-09-03 2009-09-03 Methods and compositions for the treatment of cancer
PCT/US2010/025801 WO2010110993A2 (fr) 2009-03-24 2010-03-01 Méthodes et compositions pour le traitement du cancer

Publications (2)

Publication Number Publication Date
EP2411031A2 EP2411031A2 (fr) 2012-02-01
EP2411031A4 true EP2411031A4 (fr) 2012-08-01

Family

ID=42781750

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10756546A Withdrawn EP2411031A4 (fr) 2009-03-24 2010-03-01 Méthodes et compositions pour le traitement du cancer

Country Status (5)

Country Link
EP (1) EP2411031A4 (fr)
JP (1) JP2012521424A (fr)
AU (1) AU2010229167A1 (fr)
CA (1) CA2756452A1 (fr)
WO (1) WO2010110993A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103599237B (zh) * 2013-11-28 2015-06-03 姜永华 一种治疗瘀阻胃络型胃癌的中药及其制备方法
EP3476227A4 (fr) * 2016-06-24 2020-02-05 Suntory Holdings Limited Composition permettant d'empêcher le brunissement et utilisation de la composition permettant d'empêcher le brunissement
CN110346494B (zh) * 2019-06-03 2021-09-28 云南农业大学 一种同时测定灯盏花中4种有效成分含量的方法
CN113018347B (zh) * 2021-03-01 2022-07-22 中国药科大学 一种中药提取物纳米粒及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010028187A2 (fr) * 2008-09-03 2010-03-11 Bionovo, Inc. Procédés et compositions destinés au traitement du cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE150647T1 (de) * 1989-11-03 1997-04-15 Alexander S Sun Phytotherapie von krebs
US6294526B1 (en) * 1998-02-06 2001-09-25 Alps Pharmaceutical Ind. Co., Ltd. Use of flavone derivatives for induction of β-lactam-sensitivity of MRSA
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010028187A2 (fr) * 2008-09-03 2010-03-11 Bionovo, Inc. Procédés et compositions destinés au traitement du cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HOPE RUGO ET AL: "Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer", BREAST CANCER RESEARCH AND TREATMENT, SPRINGER, NEW YORK, NY, vol. 105, no. 1, 1 September 2007 (2007-09-01), USA, pages 17 - 28, XP002620818, ISSN: 0167-6806, DOI: 10.1007/S10549-006-9430-6 *

Also Published As

Publication number Publication date
WO2010110993A2 (fr) 2010-09-30
CA2756452A1 (fr) 2010-09-30
EP2411031A2 (fr) 2012-02-01
AU2010229167A1 (en) 2011-10-20
JP2012521424A (ja) 2012-09-13
WO2010110993A3 (fr) 2011-01-13

Similar Documents

Publication Publication Date Title
IL258794B (en) Methods and preparations for the diagnosis and treatment of cancer
IL225471A0 (en) Preparations and methods for the prevention and treatment of cancer
HK1159498A1 (en) Methods and compositions for the treatment of cancer
IL218987A0 (en) Methods and compositions for treating cancer
IL214255A0 (en) Methods and compositions for diagnosis and treatment of cancer
IL251083B (en) Compounds and preparations for the treatment of cancer
EP2340027A4 (fr) Procédés et compositions destinés au traitement du cancer
IL214349A0 (en) Compositions and methods for the treatment of cancer
HK1166305A1 (zh) 用於治療炎症的組合物及方法
EP2480687A4 (fr) Méthodes et compositions pour le diagnostic et le traitement du cancer de la thyroïde
EP2558085A4 (fr) Compositions et procédés pour la prévention et le traitement du cancer
EP2419136A4 (fr) Compositions et procédés destinés au traitement du cancer
IL240560A0 (en) Preparations and methods for tumor diagnosis and treatment
EP2437738A4 (fr) Procédés et compositions pour le traitement du cancer
EP2150270A4 (fr) Méthodes et compositions pour traiter le cancer
EP2635273A4 (fr) Compositions d'isoflavonoïdes et méthodes de traitement du cancer
EP2411031A4 (fr) Méthodes et compositions pour le traitement du cancer
EP2547368A4 (fr) Méthodes et compositions pour le traitement du cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20111021

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120703

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/534 20060101AFI20120627BHEP

Ipc: A61P 35/00 20060101ALI20120627BHEP

Ipc: A61K 31/352 20060101ALI20120627BHEP

Ipc: A61K 31/37 20060101ALI20120627BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130131